We are delighted that Maitreyi has been awarded an Academy of Medical Sciences Springboard Award, which aims to support early career researchers within the biomedical sciences.
The COVID-19 pandemic, and SARS and MERS outbreaks in recent years has highlighted to need for new antiviral therapies. Through this grant, we will be developing novel host-targeting antivirals against current and emerging coronaviruses.
Viruses typically hijack several host cell pathways, and targeting key proteins required by coronaviruses will allow us to identify new broad-spectrum antivirals that can target all coronavirus infections.
We'd like to thank the Academy of Medical Sciences, and the Springboard programme funders, Department for Science, Innovation and Technology (DSIT), Wellcome, British Heart Foundation, and Diabetes UK, for the opportunity to undertake this research and support the lab.